Inflated Valuation Will Choke Revenue Amid Tighter Global Scrutiny
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
14 Apr 25
Updated
20 Aug 25
AnalystLowTarget's Fair Value
US$18.00
50.7% overvalued intrinsic discount20 Aug
US$27.12
1Y
-67.1%7D
-3.2%